Global and United States Infectious Disease Therapeutics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Infectious Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Drugs
  • 1.2.3 Vaccines
• 1.3 Market by Application
  • 1.3.1 Global Infectious Disease Therapeutics Market Share by Application: 2020 VS 2026
  • 1.3.2 HIV/AIDS
  • 1.3.3 Influenza
  • 1.3.4 Hepatitis
  • 1.3.5 Malaria
  • 1.3.6 Tuberculosis
  • 1.3.7 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Infectious Disease Therapeutics Market Perspective (2015-2026)
• 2.2 Global Infectious Disease Therapeutics Growth Trends by Regions
  • 2.2.1 Infectious Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Infectious Disease Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Infectious Disease Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Infectious Disease Therapeutics Players by Market Size
  • 3.1.1 Global Top Infectious Disease Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global Infectious Disease Therapeutics Revenue Market Share by Players (2015-2020)
• 3.2 Global Infectious Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Infectious Disease Therapeutics Revenue
• 3.4 Global Infectious Disease Therapeutics Market Concentration Ratio
  • 3.4.1 Global Infectious Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Therapeutics Revenue in 2019
• 3.5 Key Players Infectious Disease Therapeutics Area Served
• 3.6 Key Players Infectious Disease Therapeutics Product Solution and Service
• 3.7 Date of Enter into Infectious Disease Therapeutics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Disease Therapeutics Breakdown Data by Type (2015-2026)

• 4.1 Global Infectious Disease Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global Infectious Disease Therapeutics Forecasted Market Size by Type (2021-2026)

5 Infectious Disease Therapeutics Breakdown Data by Application (2015-2026)

• 5.1 Global Infectious Disease Therapeutics Historic Market Size by Application (2015-2020)
• 5.2 Global Infectious Disease Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Infectious Disease Therapeutics Market Size (2015-2026)
• 6.2 North America Infectious Disease Therapeutics Market Size by Type (2015-2020)
• 6.3 North America Infectious Disease Therapeutics Market Size by Application (2015-2020)
• 6.4 North America Infectious Disease Therapeutics Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Infectious Disease Therapeutics Market Size (2015-2026)
• 7.2 Europe Infectious Disease Therapeutics Market Size by Type (2015-2020)
• 7.3 Europe Infectious Disease Therapeutics Market Size by Application (2015-2020)
• 7.4 Europe Infectious Disease Therapeutics Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Infectious Disease Therapeutics Market Size (2015-2026)
• 8.2 China Infectious Disease Therapeutics Market Size by Type (2015-2020)
• 8.3 China Infectious Disease Therapeutics Market Size by Application (2015-2020)
• 8.4 China Infectious Disease Therapeutics Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Infectious Disease Therapeutics Market Size (2015-2026)
• 9.2 Japan Infectious Disease Therapeutics Market Size by Type (2015-2020)
• 9.3 Japan Infectious Disease Therapeutics Market Size by Application (2015-2020)
• 9.4 Japan Infectious Disease Therapeutics Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Infectious Disease Therapeutics Market Size (2015-2026)
• 10.2 Southeast Asia Infectious Disease Therapeutics Market Size by Type (2015-2020)
• 10.3 Southeast Asia Infectious Disease Therapeutics Market Size by Application (2015-2020)
• 10.4 Southeast Asia Infectious Disease Therapeutics Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Novartis AG
  • 11.1.1 Novartis AG Company Details
  • 11.1.2 Novartis AG Business Overview
  • 11.1.3 Novartis AG Infectious Disease Therapeutics Introduction
  • 11.1.4 Novartis AG Revenue in Infectious Disease Therapeutics Business (2015-2020))
  • 11.1.5 Novartis AG Recent Development
• 11.2 Gilead
  • 11.2.1 Gilead Company Details
  • 11.2.2 Gilead Business Overview
  • 11.2.3 Gilead Infectious Disease Therapeutics Introduction
  • 11.2.4 Gilead Revenue in Infectious Disease Therapeutics Business (2015-2020)
  • 11.2.5 Gilead Recent Development
• 11.3 GlaxoSmithKline plc
  • 11.3.1 GlaxoSmithKline plc Company Details
  • 11.3.2 GlaxoSmithKline plc Business Overview
  • 11.3.3 GlaxoSmithKline plc Infectious Disease Therapeutics Introduction
  • 11.3.4 GlaxoSmithKline plc Revenue in Infectious Disease Therapeutics Business (2015-2020)
  • 11.3.5 GlaxoSmithKline plc Recent Development
• 11.4 Janssen Pharmaceutical Inc.
  • 11.4.1 Janssen Pharmaceutical Inc. Company Details
  • 11.4.2 Janssen Pharmaceutical Inc. Business Overview
  • 11.4.3 Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Introduction
  • 11.4.4 Janssen Pharmaceutical Inc. Revenue in Infectious Disease Therapeutics Business (2015-2020)
  • 11.4.5 Janssen Pharmaceutical Inc. Recent Development
• 11.5 F. Hoffmann-La Roche Ltd.
  • 11.5.1 F. Hoffmann-La Roche Ltd. Company Details
  • 11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
  • 11.5.3 F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Introduction
  • 11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Infectious Disease Therapeutics Business (2015-2020)
  • 11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
• 11.6 BioCryst Pharmaceuticals Inc.
  • 11.6.1 BioCryst Pharmaceuticals Inc. Company Details
  • 11.6.2 BioCryst Pharmaceuticals Inc. Business Overview
  • 11.6.3 BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Introduction
  • 11.6.4 BioCryst Pharmaceuticals Inc. Revenue in Infectious Disease Therapeutics Business (2015-2020)
  • 11.6.5 BioCryst Pharmaceuticals Inc. Recent Development
• 11.7 Merck & Co. Inc.
  • 11.7.1 Merck & Co. Inc. Company Details
  • 11.7.2 Merck & Co. Inc. Business Overview
  • 11.7.3 Merck & Co. Inc. Infectious Disease Therapeutics Introduction
  • 11.7.4 Merck & Co. Inc. Revenue in Infectious Disease Therapeutics Business (2015-2020)
  • 11.7.5 Merck & Co. Inc. Recent Development
• 11.8 Boehringer Ingelheim GmbH
  • 11.8.1 Boehringer Ingelheim GmbH Company Details
  • 11.8.2 Boehringer Ingelheim GmbH Business Overview
  • 11.8.3 Boehringer Ingelheim GmbH Infectious Disease Therapeutics Introduction
  • 11.8.4 Boehringer Ingelheim GmbH Revenue in Infectious Disease Therapeutics Business (2015-2020)
  • 11.8.5 Boehringer Ingelheim GmbH Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer